Email this article 
Hide
Show all
Forum
Approaches to tenofovir and abacavir drug shortages in South Africa: A guide for clinicians
Southern African Journal of HIV Medicine | Vol 13, No 2 | a138 |
DOI: https://doi.org/10.4102/sajhivmed.v13i2.138
| © 2012 Laurie Schowalter, Francesca Conradie
| This work is licensed under CC Attribution 4.0
Submitted: 15 December 2012 | Published: 07 June 2012
Submitted: 15 December 2012 | Published: 07 June 2012
About the author(s)
Laurie Schowalter, Southern African HIV Clinicians SocietyFrancesca Conradie, Southern African HIV Clinicians Society
Abstract
Shortages of the nucleoside reverse transcriptase inhibitors (NRTI) abacavir and tenofovir have been reported recently at health facilities across South Africa. The Society issued the following clinical advice to healthcare providers experiencing shortages on 29 March 2012. These recommendations are intended only as a guide to clinical therapy, based on expert consensus and best available evidence. Treatment decisions for patients should be made by their responsible clinicians, with due consideration for individual circumstances.
S Afr J HIV Med 2012;13(2):56-57.
S Afr J HIV Med 2012;13(2):56-57.
Keywords
No related keywords in the metadata.
Metrics
Total abstract views: 3871Total article views: 4665
Crossref Citations
1. The impact of pharmaceutical tendering on prices and market concentration in South Africa over a 14-year period
Olivier J. Wouters, Dale M. Sandberg, Anban Pillay, Panos G. Kanavos
Social Science & Medicine vol: 220 first page: 362 year: 2019
doi: 10.1016/j.socscimed.2018.11.029
2. A randomized clinical trial comparing metabolic parameters after 48 weeks of standard‐ and low‐dose stavudine therapy and tenofovir disoproxil fumarate therapy in HIV‐infected South African patients
CN Menezes, NJ Crowther, R Duarte, D Van Amsterdam, D Evans, C Dickens, T Dix‐Peek, M Rassool, A Prinsloo, F Raal, I Sanne
HIV Medicine vol: 15 issue: 1 first page: 3 year: 2014
doi: 10.1111/hiv.12074